Skip to main content Skip to main menu
UF Health University of Florida

College of Pharmacy

UNIVERSITY of FLORIDA

Apply to Pharm.D. Program
Almut Winterstein

Almut Winterstein, R.Ph., Ph.D., FISPE

Professor & Chair; Director, Center For Drug Evaluation & Safety (CoDES)

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6258
Business Email: almut@ufl.edu
CV: View Curriculum Vitae

About Almut Winterstein

Almut Winterstein received her pharmacy degree from Friedrich Wilhelm University in Bonn, Germany and her PhD in Pharmacoepidemiology from the Charité Humboldt University in Berlin, Germany. She holds the position of Professor and Chair in the Department of Pharmaceutical Outcomes and Policy at the College of Pharmacy and is the founding Director of the Center for Drug Evaluation and Safety, both at the University of Florida. She has an affiliate appointment in the Department of Epidemiology at the Colleges of Medicine and Public Health and Health Professions. In 2017, she was named the Dr. Robert and Barbara Crisafi Chair for Medication Safety in recognition of her research on drug safety and on devising ways to improve medication use.

Since joining the University of Florida in 2000, Winterstein has served as principal investigator on more than 25 extramurally funded grants and contracts and published more than 400 manuscripts and conference abstracts. Her research interests have centered on the post-marketing evaluation of drugs in pediatrics and perinatal care, infectious disease and psychiatry and the evaluation and improvement of quality surrounding medication use using real-world data. As expert in drug safety, she has chaired the Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee from 2012-2018. Recognizing her contributions in pharmacoepidemiology, Dr. Winterstein was inducted as a fellow of the International Society of Pharmacoepidemiology in 2013 and currently serves as president of the society. Before she became department chair in 2016, Dr. Winterstein served as graduate program director in her department. She has chaired more than 21 PhD committees and was awarded the UF-wide Dissertation Advisor/Mentoring award for her excellence in graduate training.

Related Links:
Mentorship Philosophy

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-6518-5961

Areas of Interest
  • Patient Safety
  • Pharmacoepidemiology
  • Program evaluation

Publications

2020
Age of First Use of Prescription Opioids and Prescription Opioid Non-Medical Use among Older Adolescents.
Substance use & misuse
2020
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy.
Pharmacoepidemiology and drug safety
2020
Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women.
Pharmacoepidemiology and drug safety
2020
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.
Drug safety
2020
Thiazide Exposure and Cardiovascular Risk in Type 2 Diabetes Mellitus: A Point of Clarification.
Hypertension (Dallas, Tex. : 1979)
2020
Sex differences in peer and parental risk factors for non-medical use of prescription opioids in youth.
The American journal of drug and alcohol abuse
2020
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study.
Pharmacoepidemiology and drug safety
2020
Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study.
Clinical pharmacology and therapeutics
2020
Risk for Tympanic Membrane Perforation After Quinolone Ear Drops for Acute Otitis Externa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2020
Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
Circulation. Cardiovascular quality and outcomes
2020
Randomization versus Real-World Evidence.
The New England journal of medicine
2020
Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.
Pharmacotherapy
2020
Agreement of Minimum Data Set 3.0 depression and behavioral symptoms with clinical diagnosis in a nursing home.
Aging & mental health
2020
Medication Use for ADHD and the Risk of Driving Citations and Crashes Among Teenage Drivers: A Population-Based Cohort Study.
Journal of attention disorders
2020
Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.
Pharmacoepidemiology and drug safety
2020
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic.
Research in social & administrative pharmacy : RSAP
2020
Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization.
Journal of the Pediatric Infectious Diseases Society
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry.
Journal of clinical medicine
2020
Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention.
Clinical and translational science
2020
Appropriateness of Otic Quinolone Use among Privately Insured US Patients.
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
2020
Development and Validation of an Administrative Claims-based Measure for All-cause 30-day Risk-standardized Readmissions After Discharge From Inpatient Psychiatric Facilities.
Medical care
2020
Letter by Alipour Haris et al Regarding Article, “Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis”.
Stroke
2020
Machine Learning in Drug Discovery and Development Part 1: A Primer.
CPT: pharmacometrics & systems pharmacology
2020
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
BMJ quality & safety
2019
Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD.
Journal of attention disorders
2019
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology-What’s Next?-Joining Mechanistic and Epidemiological Approaches.
CPT: pharmacometrics & systems pharmacology
2019
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.
Journal of clinical medicine
2019
Predicting medication-associated altered mental status in hospitalized patients: Development and validation of a risk model.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2019
Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Pharmacotherapy
2019
Sex differences in patterns of prescription opioid non-medical use among 10-18 year olds in the US.
Addictive behaviors
2019
Variation of the prevalence of pediatric polypharmacy: A scoping review.
Pharmacoepidemiology and drug safety
2019
Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
PLoS medicine
2019
Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Drug and alcohol dependence
2019
Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.
Pharmacoepidemiology and drug safety
2019
Performance of the Centers for Medicare & Medicaid Services’ Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose.
JAMA
2019
The International Society for Pharmacoepidemiology’s Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) – EMA Joint Big Data Task Force.
Pharmacoepidemiology and drug safety
2019
Pain Assessments in MDS 3.0: Agreement with Vital Sign Pain Records of Nursing Home Residents.
Journal of the American Geriatrics Society
2019
Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
JAMA network open
2019
Common inpatient hypoglycemia phenotypes identified from an automated electronic health record-based prediction model.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2019
Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.
Journal of clinical hypertension (Greenwich, Conn.)
2019
Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis.
Drug and alcohol dependence
2019
Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
Pharmacotherapy
2019
Immeasurable Time Bias In Exposure to Ivacaftor.
Health affairs (Project Hope)
2019
Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2019
Development and validation of an automated algorithm for identifying patients at higher risk for drug-induced acute kidney injury.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2019
Development and validation of a dynamic inpatient risk prediction model for clinically significant hypokalemia using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2019
Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort Study.
Pharmacotherapy
2019
Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis.
Pharmacotherapy
2019
Model-based standardization using an outcome model with random effects.
Statistics in medicine
2019
Commentary on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.
Annals of medicine
2019
Body weight, frailty, and chronic pain in older adults: a cross-sectional study.
BMC geriatrics
2018
Prevalence of ADHD in Publicly Insured Adults.
Journal of attention disorders
2018
Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
JAMA network open
2018
Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999-2010.
Psychiatric services (Washington, D.C.)
2018
Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010.
Pharmacoepidemiology and drug safety
2018
Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy.
Journal of child and adolescent psychopharmacology
2018
Use of Systemic Antibiotics for Acute Otitis Externa: Impact of a Clinical Practice Guideline.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.
Pharmacoepidemiology and drug safety
2018
Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate.
CPT: pharmacometrics & systems pharmacology
2018
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
JACC. Cardiovascular interventions
2018
Defining pediatric polypharmacy: A scoping review.
PloS one
2018
Development and validation of an automated algorithm for identifying patients at high risk for drug-induced hypoglycemia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2018
A Bayesian nonparametric approach to causal inference on quantiles.
Biometrics
2018
A dynamic risk model for inpatient falls.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2018
A transdisciplinary team approach to scoping reviews: the case of pediatric polypharmacy.
BMC medical research methodology
2018
Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2018
Clinical utility and perils of prescription drug monitoring program-based alert systems.
Pain
2018
Association of Age With Risk of Hospitalization for Respiratory Syncytial Virus in Preterm Infants With Chronic Lung Disease.
JAMA pediatrics
2018
Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
Journal of affective disorders
2017
Institutional profile: University of Florida Health Personalized Medicine Program.
Pharmacogenomics
2017
Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Pharmacotherapy
2017
Trends in Antiepileptic Drug Use in Children and Adolescents With Epilepsy.
Pediatric neurology
2017
Quinolone Ear Drops After Tympanostomy Tubes and the Risk of Eardrum Perforation: A Retrospective Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2017
Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999-2010.
Psychiatric services (Washington, D.C.)
2017
Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.
Journal of child and adolescent psychopharmacology
2017
Measurement of selected preventable adverse drug events in electronic health records: Toward developing a complexity score.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2017
Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2017
Development of a Medication Safety and Quality Survey for Small Rural Hospitals.
Journal of patient safety
2017
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2017
Determinants of Pharmacological Treatment Initiation and Persistence in Publicly Insured Adults With Attention-Deficit/Hyperactivity Disorder.
Journal of clinical psychopharmacology
2017
Consistency of psychotropic drug-drug interactions listed in drug monographs.
Journal of the American Pharmacists Association : JAPhA
2017
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
International journal of antimicrobial agents
2017
Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
The Journal of clinical psychiatry
2016
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides.
Pharmacoepidemiology and drug safety
2016
Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking.
Journal of substance abuse treatment
2016
Sequential BART for imputation of missing covariates.
Biostatistics (Oxford, England)
2016
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study.
Pediatrics
2016
Development of a refill pattern method to measure polypharmacy in administrative claims databases.
Pharmacoepidemiology and drug safety
2016
Epidemiology of Persistent Tympanic Membrane Perforations Subsequent to Tympanostomy Tubes Assessed With Real World Data.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2015
Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2015
Clinical and Sociodemographic Factors Associated With Attention-Deficit/Hyperactivity Disorder in Patients With Cystic Fibrosis.
Psychosomatics
2015
Patient understanding of drug risks: an evaluation of medication guide assessments.
Pharmacoepidemiology and drug safety
2014
Stimulant Effectiveness On Driving Citations and Crashes of Children With Adhd
Pharmacoepidemiology and Drug Safety
2014
Risk of Sudden Sensorineural Hearing Loss in Adults Using Phosphodiesterase Type 5 Inhibitors
Pharmacoepidemiology and Drug Safety
2014
RE: Drug risk assessment and data reuse.
Pharmacoepidemiology and drug safety
2014
Psychotropic drug utilization in children with concurrent attention-deficit/hyperactivity disorder and anxiety.
Journal of anxiety disorders
2014
Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.
The international journal of neuropsychopharmacology
2014
Predicting Linkage Within a Validated Algorithm That Identifies Mother-Infant Pairs Within the Medicaid Analytic Extract (Max) Database
Pharmacoepidemiology and Drug Safety
2014
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Current medical research and opinion
2014
Negative Results Do Not Imply Absence of Ototoxicity with Middle Ear Application of Neomycin.
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
2014
Methods to estimate gestational age can significantly affect study results–reply.
JAMA pediatrics
2014
Measurement Bias in Billing Data – a Simulation Study
Pharmacoepidemiology and Drug Safety
2014
Epidemiology of Pre-Existing Diabetes in Pregnancy From 2000-2006 Among Medicaid Patients in 29 Us States
Pharmacoepidemiology and Drug Safety
2014
Diabetogenic Effects of Atypical Antipsychotics Exploration of Measurement Bias
Pharmacoepidemiology and Drug Safety
2014
Development of a Novel Approach To Assess Psychotropic Polypharmacy in Administrative Databases
Pharmacoepidemiology and Drug Safety
2014
Comparison of Rates of Prescribing Oral Corticosteroids for Asthma Exacerbations Between Step-Down Therapy Approaches Among Initiators of Inhaled Corticosteroids and Long-Acting Beta-Agonist Combination Therapy
2014
Authors’ responses in response to the letter from Ambrose.
Pediatrics
2014
Anti-diabetic drug utilization of pregnant diabetic women in us managed care.
BMC pregnancy and childbirth
2014
Misclassification in assessment of diabetogenic risk using electronic health records.
Pharmacoepidemiology and drug safety
2014
Utilization Pattern of Phosphodiesterase Type 5 (Pde5) Inhibitors for Erectile Dysfunction Among Commercially Insured Adults in the United States
Pharmacoepidemiology and Drug Safety
2013
Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study.
Journal of the American Heart Association
2013
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.
Atherosclerosis
2013
Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
JAMA pediatrics
2013
Validity of laboratory-based surveillance for detection of respiratory syncytial virus seasons.
American journal of epidemiology
2013
Risk of Suicide and Suicide Attempt Associated With Atomoxetine Compared To Central Nervous System Stimulant Treatment
Pharmacoepidemiology and Drug Safety
2013
Response to Letter to the editor regarding Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes.
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.
Pharmacoepidemiology and drug safety
2013
Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications.
Current psychiatry reports
2013
Patient Understanding of Drug Risk: Analysis of Medication Guide Assessments
Pharmacoepidemiology and Drug Safety
2013
Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes.
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
2013
Misclassification in Assessment of Diabetogenic Risk Using Laboratory-Enhanced Claims Data
Pharmacoepidemiology and Drug Safety
2013
Long-Acting Beta-Agonists and Asthma Exacerbations Requiring Short Courses of Oral Corticosteroids: a Multi-Category Exposure Marginal Structural Models Analysis
Value in Health
2013
Inclusion of Variables Associated With Exposure But Not Outcome Can Compromise Propensity Score-Based Adjustments – Examination of a Real-Life Example in Pediatric Psychopharmacology
Pharmacoepidemiology and Drug Safety
2013
Distribution and Development of Co-Morbidities in Pediatric Patients With Adhd
Pharmacoepidemiology and Drug Safety
2013
Confounding’s Ugly Little Sister: Measurement Bias in Pharmacoepidemiology
Pharmacoepidemiology and Drug Safety
2013
Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies.
Current psychiatry reports
2013
Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis.
Pediatric pulmonology
2012
Ototopical neomycin exposure in children with nonintact tympanic membranes.
The Laryngoscope
2012
Palivizumab Immunoprophylaxis Effectiveness in Children With Cystic Fibrosis
Pediatric Pulmonology
2012
Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps.
Current psychiatry reports
2012
Psychotropic Drug Utilization in Children With Concomitant Adhd and Anxiety
Pharmacoepidemiology and Drug Safety
2012
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry
2012
Use of ADHD drugs in children and young adults does not increase risk of serious cardiovascular adverse events compared with non-use.
Evidence-based mental health
2012
Trends in Utilization of Medications With Adverse Metabolic Effects in a Managed Care Population Between 1999 and 2008
Pharmacoepidemiology and Drug Safety
2012
Utilization of Antiepileptic Drugs in Florida Medicaid Women With Epilepsy of Childbearing Age
Pharmacoepidemiology and Drug Safety
2012
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply.
Archives of pediatrics & adolescent medicine
2012
Trends in Use of Benzodiazepines, Opioids, Tramadol, and Z-Drugs From 1998 To 2008 in a Managed Care Population
Pharmacoepidemiology and Drug Safety
2012
Effectiveness of palivizumab prophylaxis in infants and children in Florida.
Pharmacoepidemiology and drug safety
2012
Deterministic Linkage Between Cystic Fibrosis Patient Registry Data To Medicaid Analytical Extract Data
Pharmacoepidemiology and Drug Safety
2012
Drug Utilization Patterns for Routine Therapies in Patients With Cystic Fibrosis
Pharmacoepidemiology and Drug Safety
2012
ADHD treatment–supply or demand?
Pharmacoepidemiology and drug safety
2012
Effectiveness of Palivizumab in Respiratory Syncytial Virus Prophylaxis in Children With Cystic Fibrosis
Pharmacoepidemiology and Drug Safety
2012
An algorithm to identify preterm infants in administrative claims data.
Pharmacoepidemiology and drug safety
2012
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.
BMJ (Clinical research ed.)
2012
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
BMC medical research methodology
2012
Aminoglycoside Eardrops and Risk of Sensorineural Hearing Loss in Children With Non-Intact Tympanic Membranes
Pharmacoepidemiology and Drug Safety
2012
Deterministic Linkage Between Cystic Fibrosis Patient Registry Data and Medicaid Analytical Extract Data
Pediatric Pulmonology
2012
Drug Utilization Among Pregnant Diabetic Women in Us Managed Care
Pharmacoepidemiology and Drug Safety
2012
Determinants of Atomoxetine and Central Nervous System Stimulant Treatment Initiation
Pharmacoepidemiology and Drug Safety
2011
Do Physicians Need Both Rosiglitazone and Pioglitazone?
Pharmacoepidemiology and Drug Safety
2011
Rosiglitazone and the risk of adverse cardiovascular outcomes.
Clinical pharmacology and therapeutics
2011
Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling.
Journal of the American Pharmacists Association : JAPhA
2011
Intensive glucose lowering and cardiovascular outcomes.
The New England journal of medicine
2011
Hip Osteoarthritis MRI Scoring System (HOAMS): reliability and associations with radiographic and clinical findings.
Osteoarthritis and cartilage
2011
Health Related Quality of Life as Confounder in Observational Studies for Localized Prostate Cancer
Pharmacoepidemiology and Drug Safety
2011
Generalizability of Risk Evaluation and Mitigation Strategies (Rems) Effectiveness Evaluations
Pharmacoepidemiology and Drug Safety
2011
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.
Archives of pediatrics & adolescent medicine
2011
Utilization of Atomoxetine and Other Pharmacotherapy in Youths With Attention Deficit/Hyperactivity Disorder in Medicaid Patients in 29 Us States
American Journal of Epidemiology
2011
Atomoxetine Utilization in Youths With Attention Deficit/Hyperactivity Disorder in 29 Medicaid States
Pharmacoepidemiology and Drug Safety
2011
Association of Cesarean Section Delivery Among Pregnant Women With Diabetes.
American Journal of Epidemiology
2011
Appropriateness of Age Thresholds for Palivizumab Prophylaxis in Preterm Infants
Pharmacoepidemiology and Drug Safety
2011
An in-depth analysis of medication errors in hospitalized patients with HIV.
The Annals of pharmacotherapy
2011
Age-Dependent Effectiveness of Rsv Immunoprophylaxis
Pharmacoepidemiology and Drug Safety
2011
Adhd Youths’ Career in Psychotropic Treatment
Pharmacoepidemiology and Drug Safety
2011
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
The Annals of pharmacotherapy
2011
[Endovascular brachytherapy (EVBT) with Rhenium-188 for restenosis prophylaxis after angioplasty of infrainguinal lesions: early experience].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
2011
Comparing Pulmonary-Related Outcomes for Newborn-Screened Versus Conventional-Diagnosed Infants With Cystic Fibrosis
Pharmacoepidemiology and Drug Safety
2010
Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2010
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2010
Reply To Discussion of `Empirical Vs Natural Weighting in Random Effects Meta-Analysis’
Statistics in Medicine
2010
Projecting the effect of nesiritide on dialysis and hospital mortality in cardiac surgery patients.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2010
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
Pharmacoepidemiology and drug safety
2010
Perioperative medication errors in otolaryngology.
The Laryngoscope
2010
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida.
The Journal of pediatrics
2010
Latitude as a Factor in Rsv Epidemiology in Florida
American Journal of Epidemiology
2010
Evaluation of consumer medication information dispensed in retail pharmacies.
Archives of internal medicine
2010
Comparison of Rsv Seasonality in Four States
American Journal of Epidemiology
2009
Validation of the National Respiratory and Enteric Virus Surveillance System for the Detection of Respiratory Syncytial Virus Seasons
Pharmacoepidemiology and Drug Safety
2009
Usefulness of Consumer Medication Information (Cmi)
Pharmacoepidemiology and Drug Safety
2009
Seasonal Versus Needs-Based Immunization Schedules-the Example of Rsv
Value in Health
2009
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
The Journal of thoracic and cardiovascular surgery
2009
Patient Counseling Efforts in Us Community Pharmacies: Associations To Pharmacy and Personnel Attributes
Pharmacoepidemiology and Drug Safety
2009
Interpreting Data About Prolongation of the Q-Tc Interval Induced By Amiodarone and Haloperidol
American Journal of Health-System Pharmacy
2009
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
Pediatrics
2009
Effectiveness of Palivizumab in Medicaid Infants
Pharmacoepidemiology and Drug Safety
2009
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Journal of child and adolescent psychopharmacology
2009
Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab From the Perspective of a Southern Us Medicaid Agency
Value in Health
2009
Atomoxetine (Ato) Use and Central Nervous System Stimulants (Cnss) Use During Physician-Office Visit for Attention Deficit/Hyperactivity Disorders (Adhd) After the Discussion On Ato Related Suicidal Risk
Pharmacoepidemiology and Drug Safety
2009
Effects of Preexisting Cardiovascular Risk Factors On Initiation of Stimulants in Adults Newly Diagnosed With Adhd
Pharmacoepidemiology and Drug Safety
2008
Predicted Impact of Nesiritide On Dialysis and All-Cause Hospital Mortality in Patients Undergoing Cardiac Surgery By Demonstrated Improvement in Post-Operative Glomerular Filtration Rate
Journal of the American College of Cardiology
2008
Validity and reliability of measurement instruments used in research.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2008
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
The Annals of pharmacotherapy
2008
Treatment Persistence Among Youths Newly Diagnosed With Attention-Deficit/Hyperactivity Disorder (Adhd)
Pharmacoepidemiology and Drug Safety
2008
Role of Age in Respiratory Syncycial Virus Infection Risk – Recommendations for Palivizumab Utilization
Pharmacoepidemiology and Drug Safety
2008
Risk of Tendon Rupture After Quinolone Use in a Us Military Population
Pharmacoepidemiology and Drug Safety
2008
Response to respiratory synctial virus.
Southern medical journal
2008
Predicted Impact of Nesiritide On Dialysis and All-Cause Hospital Mortality in Cardiac Surgery Patients By Demonstrated Post-Operative Gfr Change
Pharmacoepidemiology and Drug Safety
2008
An evaluation of the effects of gatifloxacin on glucose homeostasis.
Pharmacy world & science : PWS
2008
Off-Label Prescribing of Anticonvulsant Drugs – National Pattern Between 1992-2005
Pharmacoepidemiology and Drug Safety
2008
Nesiritide following maze and mitral valve surgery.
Journal of cardiac surgery
2008
Fixed Effects Models May Bias Meta-Analytic Summary Estimates
Pharmacoepidemiology and Drug Safety
2008
Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2008
Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.
The Annals of pharmacotherapy
2008
A tool kit for practice-based research.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2008
Palivizumab Utilization and Compliance With Recommendations in Florida
Pharmacoepidemiology and Drug Safety
2007
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Pediatrics
2007
Efficacy and safety of oral phenylephrine: systematic review and meta-analysis.
The Annals of pharmacotherapy
2007
Planning for pharmacy health information technology in critical access hospitals.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2007
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.
The Annals of pharmacotherapy
2006
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Pharmacotherapy
2006
Medication safety infrastructure in critical-access hospitals in Florida.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2006
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery.
Clinical cardiology
2006
Automated medication error studies with audit supplementation were effectively designed and analyzed by time series.
Journal of clinical epidemiology
2005
Causes of hyperglycemia and hypoglycemia in adult inpatients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2005
Pharmacy-specific quality indicators for asthma therapy.
Research in social & administrative pharmacy : RSAP
2004
Nature and causes of clinically significant medication errors in a tertiary care hospital.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2003
Nature of preventable adverse drug events in hospitals: a literature review.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2002
Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2002
Manufacturer warnings of system-related medication errors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2002
Preventable drug-related hospital admissions.
The Annals of pharmacotherapy
2001
Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries.
Drugs & aging

Grants

Jul 2020 ACTIVE
Precision antiplatelet therapy after percutaneous coronary intervention
NATL INST OF HLTH NHLBI ·
May 2020 ACTIVE
Epidemiology and cost of RSV infections in infants and toddlers
MERCK AND COMPANY INC · Principal Investigator
Dec 2019 ACTIVE
BD&L Discovery Transactions Work Plan
MERCK AND COMPANY INC · Principal Investigator
Jul 2019 ACTIVE
Together: Transforming and Translating Discovery to Improve Health
NATL INST OF HLTH NCATS · Project Manager
Jul 2019 ACTIVE
Consortium for Medical Marijuana Clinical Outcomes Research
STATE UNIVERSITY SYSTEM OF FLORIDA · Principal Investigator
May 2019 – Sep 2019
Observational External Comparator Cohorts as Controls for Long-Term Uncontrolled Extensions to RCTs
INTL SOC FOR PHARMACOEPIDEMIOLOGY · Principal Investigator
May 2019 ACTIVE
Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older Adults
NATL INST OF HLTH NIA ·
Sep 2018 – Feb 2019
Inpatient Psychiatric Facility Outcome & Process Amendment 2 – Year 5 Option Year 4 (September 30, 2018 to February 15, 2019)
HEALTH SERVICES ADVISORY GROUP · Principal Investigator
Sep 2018 ACTIVE
Safety of Gadolinium-Enhanced MRI Exposure During Pregnancy on Adverse Fetal Outcomes
US FOOD AND DRUG ADMN · Principal Investigator
Jul 2018 ACTIVE
Advancing Personalized Hypertension Care through Big Data Science
NATL INST OF HLTH NHLBI ·
May 2018 ACTIVE
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations
NATL INST OF HLTH NIDA ·
May 2018 ACTIVE
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)
NEMOURS CHILDRENS CLINIC ·
Nov 2017 ACTIVE
Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications
GATES FOU, BILL & MELINDA ·
Sep 2017 – Sep 2018
HHSM-500-2013-13007I, Task Order # HHSM-500-T0004, Inpatient Psychiatric Facility Outcome and Process Measure Development & Maintenance_Task 2.1
HEALTH SERVICES ADVISORY GROUP · Principal Investigator
Sep 2017 – Sep 2020
Task Order: Developing the Capability of Using National Medicaid data for FDA Post-Marketing Surveillance to Assess Medication Safety During Pregnancy
BRIGHAM AND WOMENS HOSPITAL · Principal Investigator
Aug 2017 ACTIVE
Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia
NATL INST OF HLTH NIA ·
Feb 2017 – Feb 2017
TRAVEL REIMBURSEMENT AGREEMENT
HARVARD PILGRIM HEALTHCARE · Principal Investigator
Sep 2016 – Sep 2020
The Child Health Quality (CHeQ) Partnership Program
AGCY HEALTHCARE RES AND QUALITY ·
Jan 2016 – Jan 2017
evaluating changes in order sets for impatient pain
SHANDS TEACHING HOSPITAL HEALTHCARE · Principal Investigator
Sep 2015 – Jan 2018
Real-time risk stratification for hypo- or hyperglycemia
US FOOD AND DRUG ADMN · Principal Investigator
Sep 2015 – Sep 2017
inpatient psychiatric facility outcome & process measure
HEALTH SERVICES ADVISORY GROUP · Principal Investigator
Sep 2014 – Sep 2015
MIDS-141193: Inpatient Psychiatric Facility Outcome & Pr
HEALTH SERVICES ADVISORY GROUP · Principal Investigator
Jul 2013 – Jun 2016
Development and Validation of a Complexity Score to Iden
AMER SOC HLTH SYS PHARM FOU · Principal Investigator

Education

Ph.D.
1995 · Humboldt University
Pharmacy
1990 · Friedrich Wilhelm University

Contact Details

Phones:
Business:
(352) 273-6258
Emails:
Business:
almut@ufl.edu

recent news

UF researchers determine the risk of pregnancy loss associated with a commonly used immunosuppressant drug, effective risk management strategies are warranted

The research provides important information to support the FDA’s REMS program which aims to prevent fetal exposure to mycophenolate.

UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals

The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.

UF study finds excess use of loop diuretics following initiation of dihydropyridine calcium channel blockers

The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.

Dr. Almut Winterstein presents at FDA-wide seminar

At the meeting, she was presented an “Outstanding Service Award,” for her exceptional leadership in the field of drug safety.

read more